Literature DB >> 19273609

Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.

Eric Haines1, Parham Minoo, Zhenqian Feng, Nazila Resalatpanah, Xin-Min Nie, Manuela Campiglio, Laura Alvarez, Eftihia Cocolakis, Mohammed Ridha, Mauricio Di Fulvio, Julian Gomez-Cambronero, Jean-Jacques Lebrun, Suhad Ali.   

Abstract

Characterizing mechanisms regulating mammary cell growth and differentiation is vital, as they may contribute to breast carcinogenesis. Here, we examine a cross talk mechanism(s) downstream of prolactin (PRL), a primary differentiation hormone, and epidermal growth factor (EGF), an important proliferative factor, in mammary epithelial cell growth and differentiation. Our data indicate that EGF exerts inhibitory effects on PRL-induced cellular differentiation by interfering with Stat5a-mediated gene expression independent of the PRL-proximal signaling cascade. Additionally, our data show that PRL is a potent inhibitor of EGF-induced cell proliferation. We identify tyrosine phosphorylation of the growth factor receptor-bound protein 2 (Grb2) as a critical mechanism by which PRL antagonizes EGF-induced cell proliferation by attenuating the activation of the Ras/mitogen-activated protein kinase (MAPK) pathway. Together, our results define a novel negative cross-regulation between PRL and EGF involving the Jak2/Stat5a and Ras/MAPK pathways through tyrosine phosphorylation of Grb2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273609      PMCID: PMC2682022          DOI: 10.1128/MCB.00034-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

Authors:  E J Lowenstein; R J Daly; A G Batzer; W Li; B Margolis; R Lammers; A Ullrich; E Y Skolnik; D Bar-Sagi; J Schlessinger
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Short-hairpin RNA-mediated stable silencing of Grb2 impairs cell growth and DNA synthesis.

Authors:  Mauricio Di Fulvio; Karen M Henkels; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2007-04-10       Impact factor: 3.575

3.  Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in Xenopus.

Authors:  R W Gupta; B J Mayer
Journal:  Oncogene       Date:  1998-10-29       Impact factor: 9.867

4.  Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.

Authors:  Y Huang; X Li; J Jiang; S J Frank
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

5.  Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.

Authors:  A J Vomachka; S L Pratt; J A Lockefeer; N D Horseman
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

6.  Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.

Authors:  H Yamashita; M Nishio; Y Ando; Z Zhang; M Hamaguchi; K Mita; S Kobayashi; Y Fujii; H Iwase
Journal:  Endocr Relat Cancer       Date:  2006-09       Impact factor: 5.678

7.  Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.

Authors:  C J Ormandy; A Camus; J Barra; D Damotte; B Lucas; H Buteau; M Edery; N Brousse; C Babinet; N Binart; P A Kelly
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

8.  Stat5a is mandatory for adult mammary gland development and lactogenesis.

Authors:  X Liu; G W Robinson; K U Wagner; L Garrett; A Wynshaw-Boris; L Hennighausen
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

9.  Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.

Authors:  Jennifer H Gutzman; Debra E Rugowski; Matthew D Schroeder; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2004-08-19

10.  A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.

Authors:  J J Lebrun; S Ali; V Goffin; A Ullrich; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more
  12 in total

1.  Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.

Authors:  Balázs Merő; László Radnai; Gergő Gógl; Orsolya Tőke; Ibolya Leveles; Kitti Koprivanacz; Bálint Szeder; Metta Dülk; Gyöngyi Kudlik; Virág Vas; Anna Cserkaszky; Szabolcs Sipeki; László Nyitray; Beáta G Vértessy; László Buday
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

2.  Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.

Authors:  Ludovica Riera; Elena Lasorsa; Chiara Ambrogio; Nadia Surrenti; Claudia Voena; Roberto Chiarle
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

Review 3.  Prolactin: The Third Hormone in Breast Cancer.

Authors:  Linda A Schuler; Kathleen A O'Leary
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

4.  The bone morphogenetic protein receptor-1A pathway is required for lactogenic differentiation of mammary epithelial cells in vitro.

Authors:  C Perotti; O Karayazi; S Moffat; C S Shemanko
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-06-23       Impact factor: 2.416

5.  Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.

Authors:  Zhen Liu; Weiren Luo; Ying Zhou; Yan Zhen; Huiling Yang; Xiaoli Yu; Yanfen Ye; Xin Li; Hao Wang; Qinping Jiang; Yajie Zhang; Kaitai Yao; Weiyi Fang
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

6.  Grb2 monomer-dimer equilibrium determines normal versus oncogenic function.

Authors:  Zamal Ahmed; Zahra Timsah; Kin M Suen; Nathan P Cook; Gilbert R Lee; Chi-Chuan Lin; Mihai Gagea; Angel A Marti; John E Ladbury
Journal:  Nat Commun       Date:  2015-06-24       Impact factor: 14.919

7.  Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.

Authors:  Vanessa M López-Ozuna; Ibrahim Y Hachim; Mahmood Y Hachim; Jean-Jacques Lebrun; Suhad Ali
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

8.  Co-occurring protein phosphorylation are functionally associated.

Authors:  Ying Li; Xueya Zhou; Zichao Zhai; Tingting Li
Journal:  PLoS Comput Biol       Date:  2017-05-01       Impact factor: 4.475

9.  Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function.

Authors:  Iván Parra-Izquierdo; Alexander R Melrose; Jiaqing Pang; Hari Hara Sudhan Lakshmanan; Stéphanie E Reitsma; Sai Hitesh Vavilapalli; Mark K Larson; Joseph J Shatzel; Owen J T McCarty; Joseph E Aslan
Journal:  Platelets       Date:  2021-06-07       Impact factor: 4.236

10.  CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.

Authors:  Najat Binothman; Ibrahim Y Hachim; Jean-Jacques Lebrun; Suhad Ali
Journal:  EBioMedicine       Date:  2017-06-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.